Quick Takeaways
- This page summarizes Daniel M. Junius's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
- 5 reported transactions and 2 derivative rows are listed below.
- Filing timestamp: 14 May 2025, 17:00.
Daniel M. Junius - 13 May 2025 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)
- Role
- Director
- Signature
- /s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius
- Issuer symbol
- IDXX
- Transactions as of
- 13 May 2025
- Net transactions value
- -$650,896
- Form type
- 4
- Filing time
- 14 May 2025, 17:00:15 UTC
- Previous filing
- 08 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Daniel M. Junius filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 14 May 2025."
What Changed
- Previous filing in this sequence was filed on 08 May 2025.
- Current net transaction value: -$650,896.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| JUNIUS DANIEL M | Director | ONE IDEXX DRIVE, WESTBROOK | /s/ Lily J. Lu, Attorney-in-Fact for Daniel M. Junius | 14 May 2025 | 0001094159 |
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IDXX | Common Stock | Options Exercise | $345,089 | +1,404 | +42% | $245.79 | 4,708 | 13 May 2025 | Direct | |
| transaction | IDXX | Common Stock | Options Exercise | $362,712 | +1,279 | +27% | $283.59 | 5,987 | 13 May 2025 | Direct | |
| transaction | IDXX | Common Stock | Sale | $1,358,697 | -2,683 | -45% | $506.41 | 3,304 | 13 May 2025 | Direct |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | $0 | -1,404 | -100% | $0.000000 | 0 | 13 May 2025 | Common Stock | 1,404 | $245.79 | Direct | F1 |
| transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | $0 | -1,279 | -100% | $0.000000 | 0 | 13 May 2025 | Common Stock | 1,279 | $283.59 | Direct | F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2020 annual meeting of shareholders, whichever event was earlier. |
| F2 | Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on the one year anniversary of the date of grant or on the date of the 2021 annual meeting of shareholders, whichever event was earlier. |